A validated model of disease progression in IgA nephropathy

Riccardo Magistroni; Luciana Furci; Marco Leonelli; Mario Masellis; Giulia Ligabue; Leonardo Lucchi; Antonio Lupo; Brigida Brezzi; Giovanni Gambaro; Luca Manganelli; Giada Pedrazzi; Marco Ricardi; Luisa Bormioli; Alberto Albertazzi

A validated model of disease progression in IgA nephropathy

Riccardo Magistroni
, Luciana Furci
, Marco Leonelli
, Mario Masellis
, Giulia Ligabue
, Leonardo Lucchi
, Antonio Lupo
, Brigida Brezzi
, Giovanni Gambaro
, Luca Manganelli
, Giada Pedrazzi
, Marco Ricardi
, Luisa Bormioli
, Alberto Albertazzi

Università Cattolica del Sacro Cuore

University of Modena and Reggio Emilia
University of Toronto
University of Verona

Research output: Contribution to journal › Article

8 Citations (Scopus)

Abstract

IgA nephropathy (IgAN) is the most common primary glomerulonephritis in the general population. There is accumulating evidence that immunosuppressive treatment is efficacious in IgAN. However, it is critical to define appropriate indicators for this therapy especially in the wake of potentially deleterious side effects to immunosuppressives.

Original language	English
Pages (from-to)	32-40
Number of pages	9
Journal	JN. JOURNAL OF NEPHROLOGY
Volume	19
Publication status	Published - 2006

Keywords

Adolescent
Adult
Biopsy
Disease Progression
Female
Follow-Up Studies
Glomerulonephritis, IGA
Humans
Immunosuppressive Agents
Italy
Male
Prognosis
Retrospective Studies
Survival Rate

Cite this

@article{bdce7f429838429f91dae81ffa2ebae1,

title = "A validated model of disease progression in IgA nephropathy",

abstract = "IgA nephropathy (IgAN) is the most common primary glomerulonephritis in the general population. There is accumulating evidence that immunosuppressive treatment is efficacious in IgAN. However, it is critical to define appropriate indicators for this therapy especially in the wake of potentially deleterious side effects to immunosuppressives.",

keywords = "Adolescent, Adult, Biopsy, Disease Progression, Female, Follow-Up Studies, Glomerulonephritis, IGA, Humans, Immunosuppressive Agents, Italy, Male, Prognosis, Retrospective Studies, Survival Rate, Adolescent, Adult, Biopsy, Disease Progression, Female, Follow-Up Studies, Glomerulonephritis, IGA, Humans, Immunosuppressive Agents, Italy, Male, Prognosis, Retrospective Studies, Survival Rate",

author = "Riccardo Magistroni and Luciana Furci and Marco Leonelli and Mario Masellis and Giulia Ligabue and Leonardo Lucchi and Antonio Lupo and Brigida Brezzi and Giovanni Gambaro and Luca Manganelli and Giada Pedrazzi and Marco Ricardi and Luisa Bormioli and Alberto Albertazzi",

year = "2006",

language = "English",

volume = "19",

pages = "32--40",

journal = "JN. JOURNAL OF NEPHROLOGY",

issn = "1121-8428",

publisher = "Wichtig Editore:Via Friuli 72 74, I 20135 Milan Italy:011 39 02 5455122, 011 39 2 55195443, EMAIL: [email protected], INTERNET: http://www.wichtig-publisher.com, Fax: 011 39 2 55195971",

}

TY - JOUR

T1 - A validated model of disease progression in IgA nephropathy

AU - Magistroni, Riccardo

AU - Furci, Luciana

AU - Leonelli, Marco

AU - Masellis, Mario

AU - Ligabue, Giulia

AU - Lucchi, Leonardo

AU - Lupo, Antonio

AU - Brezzi, Brigida

AU - Gambaro, Giovanni

AU - Manganelli, Luca

AU - Pedrazzi, Giada

AU - Ricardi, Marco

AU - Bormioli, Luisa

AU - Albertazzi, Alberto

PY - 2006

Y1 - 2006

N2 - IgA nephropathy (IgAN) is the most common primary glomerulonephritis in the general population. There is accumulating evidence that immunosuppressive treatment is efficacious in IgAN. However, it is critical to define appropriate indicators for this therapy especially in the wake of potentially deleterious side effects to immunosuppressives.

AB - IgA nephropathy (IgAN) is the most common primary glomerulonephritis in the general population. There is accumulating evidence that immunosuppressive treatment is efficacious in IgAN. However, it is critical to define appropriate indicators for this therapy especially in the wake of potentially deleterious side effects to immunosuppressives.

KW - Adolescent

KW - Adult

KW - Biopsy

KW - Disease Progression

KW - Female

KW - Follow-Up Studies

KW - Glomerulonephritis, IGA

KW - Humans

KW - Immunosuppressive Agents

KW - Italy

KW - Male

KW - Prognosis

KW - Retrospective Studies

KW - Survival Rate

KW - Adolescent

KW - Adult

KW - Biopsy

KW - Disease Progression

KW - Female

KW - Follow-Up Studies

KW - Glomerulonephritis, IGA

KW - Humans

KW - Immunosuppressive Agents

KW - Italy

KW - Male

KW - Prognosis

KW - Retrospective Studies

KW - Survival Rate

UR - http://hdl.handle.net/10807/22858

M3 - Article

SN - 1121-8428

VL - 19

SP - 32

EP - 40

JO - JN. JOURNAL OF NEPHROLOGY

JF - JN. JOURNAL OF NEPHROLOGY

ER -

A validated model of disease progression in IgA nephropathy

Abstract

Keywords

Other files and links

Fingerprint

Cite this